ProQR Therapeutics N.V. buy Raymond James
Start price
29.10.24
/
50%
€3.19
Target price
29.10.25
€12.97
Performance (%)
-30.89%
End price
30.10.25
€2.20
Summary
This prediction ended on 30.10.25 with a price of €2.20. The BUY prediction by Raymond_James for ProQR Therapeutics N.V. performed very badly with a performance of -30.89%. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| ProQR Therapeutics N.V. | 8.375% | 8.375% | -40.913% |
| iShares Core DAX® | -0,38 % | 1,09 % | 11,64 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % | 7,27 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % | 31,38 % |
| iShares S&P 500 | -0,71 % | 0,44 % | 4,30 % |
Comments by Raymond_James for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $14.00 price target on the stock, up previously from $6.00.
Ratings data for PRQR provided by MarketBeat
In the thread Trading ProQR Therapeutics N.V.
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Raymond_James for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.27
08.11.23
08.11.23
€3.75
08.11.24
08.11.24
170.93%
09.11.24
09.11.24
